Guardian Pharmacy Services Inc

Análisis de la acción Guardian Pharmacy Services Inc (GRDN)

$40.140

+0.682 (+1.70%)Al cierre

Loading chart…
Máximo
40.400
Apertura
39.710
Precio medio ponderado por volumen
39.98
Volumen
378.65K
Capitalización
—
Mínimo
39.410
Importe
15.14M
EV/EBITDA, TTM
31.87

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.

Análisis de IA of Guardian Pharmacy Services Inc (GRDN)

Mantener

Guardian Pharmacy Services Inc is currently a hold. The stock is trading at $39.47, which is below the analyst consensus target of $49.81, indicating potential upside. However, the RSI is at 32.151, suggesting it is oversold, and the stock has seen a 5-day decline of 4.38%. The main risk is the recent performance trend, with a year-to-date change of +33.66% but a 20-day change of -12.27%, indicating volatility.

Métricas de valoración

El PER previsto actual de Guardian Pharmacy Services Inc (GRDN) es 30.21, frente a su media de 5 años de 26.70.

PER previsto

Valor razonable
Media 5A P/E
26.70
P/E actual
30.21
Sobrevalorada
30.53
Infravalorada
22.86

EV/EBITDA previsto

Muy sobrevalorado
Media 5A EV/EBITDA
18.22
EV/EBITDA actual
31.87
Sobrevalorada
23.83
Infravalorada
12.61

Precio/ventas previsto

Sobrevalorado
Media 5A P/S
1.27
P/S actual
1.63
Sobrevalorada
1.55
Infravalorada
0.99

Ballenas con GRDN en cartera

A

Aristotle Capital Boston, LLC

+ Con en carteraGRDN

-2.12%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-01 (ET)

17:00:00

Guardian Pharmacy Acquires Assets from Nautilus Pharmacy

2026-08-06 (ET)

17:01:00

Raises FY26 Adjusted EBITDA View to $129M-$131M

17:01:00

Guardian Reports Q2 Revenue of $351.8M, Beating Expectations

2026-07-01 (ET)

17:00:00

Guardian Pharmacy Acquires Wellness Concepts to Expand Virginia Operations

2026-06-22 (ET)

17:00:00

Guardian Pharmacy Executive Forbes Retires, Morris to Become COO

Noticias

Preguntas frecuentes sobre GRDN, respondidas por Alphio AI

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.

Guardian Pharmacy Services Inc is currently a hold. The stock is trading at $39.47, which is below the analyst consensus target of $49.81, indicating potential upside. However, the RSI is at 32.151, suggesting it is oversold, and the stock has seen a 5-day decline of 4.38%. The main risk is the recent performance trend, with a year-to-date change of +33.66% but a 20-day change of -12.27%, indicating volatility.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar